14/11/2017 18:29:04

SmarTech and 3DPrint.com Announces “The Future of 3D Printing in Medicine and Dentistry: A Business & Investment Summit”

CHARLOTTESVILLE, Va., Nov. 14, 2017 (GLOBE NEWSWIRE) -- On January 22 and 23, 2018 in Washington DC, SmarTech and 3DPrint.com will be holding a conference on “The Future of 3D Printing in Medicine and Dentistry” More details about this “Business & Investment Summit” can be found at https://additivemanufacturingstrategies.com.

What The Future of 3D Printing in Medicine and Dentistry: A Business & Investment Summit
WhenJanuary 22 – January 23
Where The Army and Navy Club

901 17th St NW, Washington, DC 20006

Registration

https://additivemanufacturingstrategies.com/register/?options=registration

 

Save 25%, register by November 15

 

For more details (917) 403-6300

ams@3dprint.com

  • This is the first business-oriented conference focused on additive manufacturing in the medical and dental sectors.  Attendees will have the opportunity to hear senior executives from 3D Systems, Carbon, EOS, GE Additive, HP, Materialise, Oxford Performance Materials, Stratasys, along with innovative start-ups discuss how they plan to capture revenues from this multi-billion dollar opportunity. In addition, there will be presentations from leading practitioners on where they are seeing the advantages for additive manufacturing emerge in hospitals, labs and doctor’s offices.

     

  • SmarTech's analysts will also be at the Summit; giving our view of where medical/dental 3DP is headed commercially as well as sharing our latest medical and dental 3DP forecasts. SmarTech is the leading industry analyst firm specializing the additive manufacturing space and has published numerous market studies on medical and dental 3DP as well as carrying out demanding consulting work in these areas. At the Summit, our analysts will provide a realistic view of what 3D-printing applications will become a standard fabrication process and which will stay in the medical and dental labs for years to come. Our analysts will also provide insight into the value chains that will emerge in this area.

     

  • Summit Attendees will also gain insight into where the investment money will be coming from for “additive medicine and dentistry,” and what kind of financial deals will be struck in this area in the coming years. It will also provide clarity on how intellectual property and regulatory factors will impact investment considerations in this area

“The Future of 3D Printing in Medicine and Dentistry: A Business & Investment Summit” is designed to guide managers, entrepreneurs and investors to the most profitable opportunities in 3D-printed prosthetics, implants, medical models and personal medicine, as well as bioprinting and 3D-printed dental devices – sectors that will generate more than $5 billion in revenues by 2021, according to SmarTech’s latest analysis.

In addition to being source of information on the latest developments in medical and dental 3D printing, this must-attend conference will provide the kind of environment where alliances will be formed and deals will be done between important players in the 3DP space.  It is intended for marketing, business development and product management as well as investors and healthcare professionals of all kinds.

For further details:

(917) 403-6300

ams@3dprint.com

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
15 Jun
PNDORA
Carnegie´s senste negative udmeldning omkring en lille analyse foretaget blandt nogle franchisetager..
30
16 Jun
PNDORA
Som Pandora aktionær er jeg meget tilfreds med ledelsens indsats og de skabte resultater. Ledelsen l..
21
14 Jun
 
Jeg har et par gange øffet over niveauet herinde i dette debatforum. I første omgang skrev jeg til b..
18
18 Jun
PNDORA
              Jeg har lavet en fuld analyse på Pandora, som er en blanding af en regnskabs-analyse o..
17
16 Jun
VELO
Her er mit bud på begivenheder og dato for disse de næste 200 dage. Det bliver en god jul i år som i..
14
16 Jun
VWS
Nu er det jo Vestas der er mindst ramt af prispres, da de selv presser priser ned, da målet er at vi..
14
16 Jun
VWS
http://globenewswire.com/news-release/2018/06/15/1525456/0/en/Vestas-secures-442-MW-order-from-Xcel-..
13
14 Jun
VELO
Endnu et studie med Envarsus er startet op. Denne gang af Washington University School of Medicine. ..
13
19 Jun
VWS
https://www.vestas.com/en/media/company-news?n=1763161#!NewsView
12
14 Jun
PNDORA
Mange har snart mistet så mange penge på pandora, at de eneste smykker de har råd til at købe til ko..
12

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
SANOFI COMPLETES ITS ACQUITISION OF ABLYNX FOLLOWING THE EXPIRATION OF THE SQUEEZE-OUT PROCEDURE
2
Publishing of Sponda's Half Year Financial Report January - June 2018
3
Roche and Foundation Medicine reach definitive merger agreement to accelerate broad availability of comprehensive genomic profiling in oncology
4
BioSolar Signs a Joint Development Agreement with Ferroglobe, the Global Leader in the Supply of Silicon Material
5
Hofseth Biocare ASA: Key information relating to the repair issue

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
20 June 2018 03:09:58
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180619.1 - EUROWEB1 - 2018-06-20 04:09:58 - 2018-06-20 03:09:58 - 1000 - Website: OKAY